How do you treat patients with early-stage ER+/Her2- breast cancer who recur years later after definitive therapy and hormonal therapy?

Do you use cytotoxic chemotherapy as first line or hormonally-targeted therapy such as letrozole + palbociclib?

Answer from: Medical Oncologist at Community Practice

There's a lot of nuances to this question. What's the disease burden? Is there considerable visceral disease? What is the performance status of the patient? And finally, patient preference? If there is considerable visceral disease, I do consider single agent chemotherapy for a few cycles, and very ...

Please select the option that best describes you:

How do you treat patients with early-stage ER+/Her2- breast cancer who recur years later after definitive therapy and hormonal therapy?

Related Questions